id: oral_naltrexone_formulation_to_aud_medication_adherence
name: Oral Naltrexone Formulation â†’ Alcohol Use Disorder Medication Adherence
from_node:
  node_id: oral_naltrexone_formulation
  node_name: Oral Naltrexone Formulation
to_node:
  node_id: aud_medication_adherence
  node_name: Alcohol Use Disorder Medication Adherence
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Daily oral dosing requires consistent patient-initiated medication taking
  behavior'
- 'Step 2: Daily decisions about medication create multiple opportunities for missed
  doses'
- 'Step 3: Life disruptions, competing demands, and structural barriers (work schedules,
  unstable housing) interfere with daily routines'
- 'Step 4: Lack of healthcare system involvement in daily administration reduces structural
  support for adherence'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Hayden Stewart et al. 2021. "Veteran adherence to oral versus
    injectable AUD medication treatment.." *The mental health clinician*. https://doi.org/10.9740/mhc.2021.05.194
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:06.681168'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: time_on_treatment
  direction: strengthens
  strength: moderate
  description: At 9 and 12 months, acamprosate had significantly higher adherence
    compared to oral naltrexone, suggesting oral naltrexone adherence worsens over
    extended periods
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/healthcare_access/oral_naltrexone_formulation_to_aud_medication_adherence.yaml
_category: healthcare_access
